|Category:||Emerging Biotech Company|
|Time:||15:30 – 15:45 on 2 May 2022|
|Speaker:||Dr. Dominik Escher – Managing Partner|
Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. We strive to impact patients’ lives by advancing innovative treatments for severe diseases.